DATE: July 28, 2020
TIME: 9:00 am PDT, 12:00 pm EDT
The demographic profile of hepatitis B and C has seen a paradigm shift over the last 10 years and as a result clinical guidelines for hepatitis testing are changing. With updated screening recommendations on the way it is necessary to understand the role of serological markers in both diagnosis of hepatitis B virus (HBV) and monitoring HBV disease status. The best way to reduce the spread of HBV infection and to optimize patient management is through the implementation of robust serological testing; with a few caveats along the way.
Understand the shift in screening recommendation for hepatitis in the clinical guidelines based on the rise of hepatitis in younger demographics including HBV and HCV
Recognize the importance of serological markers for HBV diagnosis and management
Identify potential caveats when testing based on serological profiles and the complexity of HBV
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.